About CJC-1295 with DAC
CJC-1295 with DAC is a 30-amino-acid analogue of growth hormone-releasing hormone modified at the N-terminus for proteolytic resistance and carrying a Drug Affinity Complex, a maleimidopropionyl linker that can conjugate to serum albumin in biological systems. This conjugation markedly extends its circulating presence in experimental animals, making it a preferred tool when researchers need prolonged GHRH-receptor engagement rather than transient stimulation. Applications include studies of growth hormone pulsatility, IGF-1 production over extended time courses, and comparisons of acute versus sustained secretagogue exposure on metabolic endpoints. Synthesis and characterization of the DAC-bearing peptide are demanding: incomplete linker incorporation, maleimide hydrolysis, or albumin-conjugate instability can alter apparent potency. Shandong Shengyuan controls these variables through RP-HPLC purity certification at 99.4% or higher, LC-MS confirmation of the intact conjugate-forming peptide, and stability-directed lyophilization. The material is supplied for research use only and is not intended for human or veterinary use.
Research Applications
- Sustained GHRH receptor studies
- GH pulsatility models
- IGF-1 time-course research
- Albumin conjugation studies
- Secretagogue comparison assays
Quality & Documentation
Every batch of CJC-1295 with DAC is manufactured under our documented quality system and released with a Certificate of Analysis covering HPLC purity, mass spectrometry identity, peptide content, water content, and endotoxin. The batch code on your vial can be verified online in the COA lookup section of this site.
Tesamorelin
Sermorelin Acetate
Ipamorelin